Autopsy report · NCT03922776
Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer
Cause of deathSlow enrollment
“End of recruiting period”
Life of this trial
- Registered 4 months before it started.
- Ran for about 5 years 2 months before it stopped.
- 36 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Centre Oscar Lambret
- Sponsor type
- University, hospital or other
- Conditions
- Ovarian Cancer Stage IIIC; Fallopian Tube Cancer Stage IIIC; Fallopian Tube Cancer Stage IV; Ovarian Cancer Stage IV
- Interventions
- Blood sample collection
- Participants
- 36
- Sites
- 1
- Countries
- France
Trials that died the same way
- Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
“End of recruitment period” - A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
“end of recruitment” - Physical Activity as an Aid for Smoking Cessation
“End of the recruitment” - Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
“prolonged recruitment phase” - Olaparib for PAH: a Multicenter Clinical Trial
“The recruitment was stopped on October 31st 2024 due to limited recruitment within the last year, as well as the end of funding (Spring 2025).”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.